Kathryn studies how health care is organized, delivered, and financed. In 2018, she founded the TRANSPERS Center, which focuses on how precision medicine can be appropriately implemented. She focuses on insurer coverage, cost-effectiveness, stakeholder decision-making, and evidence synthesis. Her cross-disciplinary, cross-sector research integrates perspectives across academia, industry, health care payers, and government. She has published almost 200 articles in major journals; has led NIH grants for 30 years; is Editor-in-Chief for Health Affairs Scholar; is a member of the National Academy of Medicine Roundtable on Genomics; and has served on the governing Board of Directors for GenomeCanada and as an advisor to the FDA, CDC, President’s Council of Advisors on Science and Technology, and White House Office of Science and Technology as well as dozens of tech/pharma companies and venture capitalists. Kathryn also serves on an evidence review committee for the Institute for Clinical and Economic Review.